Cargando…

Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence

The diagnosis of Parkinson’s disease (PD) is challenging at all stages due to variable symptomatology, comorbidities, and mimicking conditions. Postmortem assessment remains the gold standard for a definitive diagnosis. While it is well recognized that PD manifests pathologically in the central nerv...

Descripción completa

Detalles Bibliográficos
Autores principales: Signaevsky, Maxim, Marami, Bahram, Prastawa, Marcel, Tabish, Nabil, Iida, Megan A., Zhang, Xiang Fu, Sawyer, Mary, Duran, Israel, Koenigsberg, Daniel G., Bryce, Clare H., Chahine, Lana M., Mollenhauer, Brit, Mosovsky, Sherri, Riley, Lindsey, Dave, Kuldip D., Eberling, Jamie, Coffey, Chris S., Adler, Charles H., Serrano, Geidy E., White, Charles L., Koll, John, Fernandez, Gerardo, Zeineh, Jack, Cordon-Cardo, Carlos, Beach, Thomas G., Crary, John F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842941/
https://www.ncbi.nlm.nih.gov/pubmed/35164870
http://dx.doi.org/10.1186/s40478-022-01318-7
_version_ 1784651151230107648
author Signaevsky, Maxim
Marami, Bahram
Prastawa, Marcel
Tabish, Nabil
Iida, Megan A.
Zhang, Xiang Fu
Sawyer, Mary
Duran, Israel
Koenigsberg, Daniel G.
Bryce, Clare H.
Chahine, Lana M.
Mollenhauer, Brit
Mosovsky, Sherri
Riley, Lindsey
Dave, Kuldip D.
Eberling, Jamie
Coffey, Chris S.
Adler, Charles H.
Serrano, Geidy E.
White, Charles L.
Koll, John
Fernandez, Gerardo
Zeineh, Jack
Cordon-Cardo, Carlos
Beach, Thomas G.
Crary, John F.
author_facet Signaevsky, Maxim
Marami, Bahram
Prastawa, Marcel
Tabish, Nabil
Iida, Megan A.
Zhang, Xiang Fu
Sawyer, Mary
Duran, Israel
Koenigsberg, Daniel G.
Bryce, Clare H.
Chahine, Lana M.
Mollenhauer, Brit
Mosovsky, Sherri
Riley, Lindsey
Dave, Kuldip D.
Eberling, Jamie
Coffey, Chris S.
Adler, Charles H.
Serrano, Geidy E.
White, Charles L.
Koll, John
Fernandez, Gerardo
Zeineh, Jack
Cordon-Cardo, Carlos
Beach, Thomas G.
Crary, John F.
author_sort Signaevsky, Maxim
collection PubMed
description The diagnosis of Parkinson’s disease (PD) is challenging at all stages due to variable symptomatology, comorbidities, and mimicking conditions. Postmortem assessment remains the gold standard for a definitive diagnosis. While it is well recognized that PD manifests pathologically in the central nervous system with aggregation of α-synuclein as Lewy bodies and neurites, similar Lewy-type synucleinopathy (LTS) is additionally found in the peripheral nervous system that may be useful as an antemortem biomarker. We have previously found that detection of LTS in submandibular gland (SMG) biopsies is sensitive and specific for advanced PD; however, the sensitivity is suboptimal especially for early-stage disease. Further, visual microscopic assessment of biopsies by a neuropathologist to identify LTS is impractical for large-scale adoption. Here, we trained and validated a convolutional neural network (CNN) for detection of LTS on 283 digital whole slide images (WSI) from 95 unique SMG biopsies. A total of 8,450 LTS and 35,066 background objects were annotated following an inter-rater reliability study with Fleiss Kappa = 0.72. We used transfer learning to train a CNN model to classify image patches (151 × 151 pixels at 20× magnification) with and without the presence of LTS objects. The trained CNN model showed the following performance on image patches: sensitivity: 0.99, specificity: 0.99, precision: 0.81, accuracy: 0.99, and F-1 score: 0.89. We further tested the trained network on 1230 naïve WSI from the same cohort of research subjects comprising 42 PD patients and 14 controls. Logistic regression models trained on features engineered from the CNN predictions on the WSI resulted in sensitivity: 0.71, specificity: 0.65, precision: 0.86, accuracy: 0.69, and F-1 score: 0.76 in predicting clinical PD status, and 0.64 accuracy in predicting PD stage, outperforming expert neuropathologist LTS density scoring in terms of sensitivity but not specificity. These findings demonstrate the practical utility of a CNN detector in screening for LTS, which can translate into a computational tool to facilitate the antemortem tissue-based diagnosis of PD in clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01318-7.
format Online
Article
Text
id pubmed-8842941
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88429412022-02-16 Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence Signaevsky, Maxim Marami, Bahram Prastawa, Marcel Tabish, Nabil Iida, Megan A. Zhang, Xiang Fu Sawyer, Mary Duran, Israel Koenigsberg, Daniel G. Bryce, Clare H. Chahine, Lana M. Mollenhauer, Brit Mosovsky, Sherri Riley, Lindsey Dave, Kuldip D. Eberling, Jamie Coffey, Chris S. Adler, Charles H. Serrano, Geidy E. White, Charles L. Koll, John Fernandez, Gerardo Zeineh, Jack Cordon-Cardo, Carlos Beach, Thomas G. Crary, John F. Acta Neuropathol Commun Research The diagnosis of Parkinson’s disease (PD) is challenging at all stages due to variable symptomatology, comorbidities, and mimicking conditions. Postmortem assessment remains the gold standard for a definitive diagnosis. While it is well recognized that PD manifests pathologically in the central nervous system with aggregation of α-synuclein as Lewy bodies and neurites, similar Lewy-type synucleinopathy (LTS) is additionally found in the peripheral nervous system that may be useful as an antemortem biomarker. We have previously found that detection of LTS in submandibular gland (SMG) biopsies is sensitive and specific for advanced PD; however, the sensitivity is suboptimal especially for early-stage disease. Further, visual microscopic assessment of biopsies by a neuropathologist to identify LTS is impractical for large-scale adoption. Here, we trained and validated a convolutional neural network (CNN) for detection of LTS on 283 digital whole slide images (WSI) from 95 unique SMG biopsies. A total of 8,450 LTS and 35,066 background objects were annotated following an inter-rater reliability study with Fleiss Kappa = 0.72. We used transfer learning to train a CNN model to classify image patches (151 × 151 pixels at 20× magnification) with and without the presence of LTS objects. The trained CNN model showed the following performance on image patches: sensitivity: 0.99, specificity: 0.99, precision: 0.81, accuracy: 0.99, and F-1 score: 0.89. We further tested the trained network on 1230 naïve WSI from the same cohort of research subjects comprising 42 PD patients and 14 controls. Logistic regression models trained on features engineered from the CNN predictions on the WSI resulted in sensitivity: 0.71, specificity: 0.65, precision: 0.86, accuracy: 0.69, and F-1 score: 0.76 in predicting clinical PD status, and 0.64 accuracy in predicting PD stage, outperforming expert neuropathologist LTS density scoring in terms of sensitivity but not specificity. These findings demonstrate the practical utility of a CNN detector in screening for LTS, which can translate into a computational tool to facilitate the antemortem tissue-based diagnosis of PD in clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01318-7. BioMed Central 2022-02-14 /pmc/articles/PMC8842941/ /pubmed/35164870 http://dx.doi.org/10.1186/s40478-022-01318-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Signaevsky, Maxim
Marami, Bahram
Prastawa, Marcel
Tabish, Nabil
Iida, Megan A.
Zhang, Xiang Fu
Sawyer, Mary
Duran, Israel
Koenigsberg, Daniel G.
Bryce, Clare H.
Chahine, Lana M.
Mollenhauer, Brit
Mosovsky, Sherri
Riley, Lindsey
Dave, Kuldip D.
Eberling, Jamie
Coffey, Chris S.
Adler, Charles H.
Serrano, Geidy E.
White, Charles L.
Koll, John
Fernandez, Gerardo
Zeineh, Jack
Cordon-Cardo, Carlos
Beach, Thomas G.
Crary, John F.
Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
title Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
title_full Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
title_fullStr Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
title_full_unstemmed Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
title_short Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
title_sort antemortem detection of parkinson’s disease pathology in peripheral biopsies using artificial intelligence
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842941/
https://www.ncbi.nlm.nih.gov/pubmed/35164870
http://dx.doi.org/10.1186/s40478-022-01318-7
work_keys_str_mv AT signaevskymaxim antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT maramibahram antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT prastawamarcel antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT tabishnabil antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT iidamegana antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT zhangxiangfu antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT sawyermary antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT duranisrael antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT koenigsbergdanielg antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT bryceclareh antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT chahinelanam antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT mollenhauerbrit antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT mosovskysherri antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT rileylindsey antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT davekuldipd antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT eberlingjamie antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT coffeychriss antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT adlercharlesh antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT serranogeidye antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT whitecharlesl antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT kolljohn antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT fernandezgerardo antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT zeinehjack antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT cordoncardocarlos antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT beachthomasg antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence
AT craryjohnf antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence